Accurate recognition of patients through imaging is crucial in the therapeutic management of acute coronary syndrome to improve outcomes.
Answers are grounded in this paper and cite their sources.
Supports imaging in ACS decisions; leaves open prospective validation before practice change.
Acute coronary syndrome is a leading cause for hospital admissions both in Europe and the United States resulting in high medical care expenses. During the past 25 years, there have been important advances in the therapeutic options for patients with an acute coronary syndrome with improved medical therapy and the introduction of percutaneous coronary intervention. However, despite the reduction of morbidity and mortality due to various refinements in medical treatment and technology, there are still opportunities to improve outcome in the first months after the event and on the longer run. Accurate recognition of patients that can benefit from additional therapies is, therefore, crucial in the therapeutic management of patients after an acute coronary syndrome.
No takes yet. Share an insight, caveat, or question.
Hirsch et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: